Wiley Blackwell

SHERPA: Unknown

People

  1. Vickers
    Vickers
  2. Horwitz
    Horwitz
  3. Panageas
    Panageas
  4. Kingham
    Kingham
  5. Halpern
    Halpern
  6. Sklar
    Sklar
  7. Begg
    Begg
  8. Offit
    Offit
  9. Robson
    Robson
  10. Korc-Grodzicki
    Korc-Grodzicki

Groups

  1. Population Sciences Research Program (614)
  2. Survivorship Research (317)
  3. Department of Medicine (280)
  4. Epidemiology and Biostatistics (280)
  5. Surgery (198)
  6. Solid Tumor Oncology Division (160)
  7. Health Outcomes Research Group (138)
  8. Biostatistics Service (135)
  9. Psychiatry and Behavioral Sciences, Department of (115)
  10. Division of Subspecialty Medicine (105)
Search Within
  1. "Population Sciences Research Program"
Formats
  1. Journal Article (474)
  2. Meeting Abstract (93)
  3. Review (14)
  4. Editorial (12)
  5. Correspondence (6)
  6. Research Letter (5)
  7. Book Section (4)
  8. Conference Paper (3)
  9. Guidelines (3)
Groups
  1. Population Sciences Research Program (614)
  2. Survivorship Research (317)
  3. Department of Medicine (280)
  4. Epidemiology and Biostatistics (280)
  5. Surgery (198)
  6. Solid Tumor Oncology Division (160)

More Groups

People
  1. Andrew Vickers (69)
  2. Steven Horwitz (55)
  3. Katherine Panageas (38)
  4. T Peter Kingham (37)
  5. Allan Halpern (31)
  6. Charles Sklar (31)

More People

Years
  1. 2025 (12)
  2. 2024 (34)
  3. 2023 (38)
  4. 2022 (37)
  5. 2021 (36)
  6. 2020 (33)

More Years

Publications
  1. Cancer (240)
  2. BJU International (66)
  3. Journal of Surgical Oncology (43)
  4. Hematological Oncology (38)
  5. Journal of the American Geriatrics Society (35)
  6. Cancer Medicine (31)

More Publications

Results (614)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Response by stage in CD30-positive (CD30+) cutaneous T cell lymphoma (CTCL) patients receiving brentuximab vedotin (BV) vs physician's choice (PC) in the Phase 3 ALCANZA study
    Meeting Abstract

    Horwitz, S.; Whittaker, S.; Duvic, M.; Dummer, R.; Kim, Y. H.; Scarisbrick, J.; Quaglino, P.; Zinzani, P.; Wolter, P.; Eradat, H.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Patient-reported outcomes and quality of life in patients with cutaneous T cell lymphoma: Results from the Phase 3 ALCANZA study
    Meeting Abstract

    Prince, H. M.; Dummer, R.; Whittaker, S.; Horwitz, S.; Duvic, M.; Scarisbrick, J.; Quaglino, P.; Zinzani, P. L.; Wolter, P.; Sanches, J.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Baseline metabolic tumor volume is an independent prognostic factor for relapsed and refractory Hodgkin lymphoma patients receiving PET-adapted salvage therapy with brentuximab vedotin and augmented ICE
    Meeting Abstract

    Moskowitz, A. J.; Schöder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Phase I/IB dose escalation and expansion of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma
    Meeting Abstract

    Batlevi, C.; Hamlin, P.; Matasar, M.; Gerecitano, J.; Drullinsky, P.; Hamilton, A.; Straus, D.; Horwitz, S.; Kumar, A.; Moskowitz, C.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Improved survival outcomes for patients with extra-nodal NK/T lymphoma: Data from 140 patients prospectively registered in the international T-cell project
    Meeting Abstract

    Fox, C. P.; Bellei, M.; Manni, M.; Kim, S. J.; Ko, Y. H.; Shustov, A. R.; Cabrera, M. E.; Chiattone, C. S.; Horwitz, S. M.; Spina, M.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Brentuximab vedotin vs physician's choice in CTCL patients from the Phase 3 ALCANZA study: Analysis of outcomes by CD30 expression
    Meeting Abstract

    Kim, Y. H.; Prince, H. M.; Whittaker, S.; Horwitz, S. M.; Duvic, M.; Scarisbrick, J.; Quaglino, P.; Zinzani, P. L.; Wolter, P.; Bechter, O.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Recurrence patterns following irreversible electroporation for hepatic malignancies
    Journal Article

    Langan, R. C.; Goldman, D. A.; D'Angelica, M. I.; DeMatteo, R. P.; Allen, P. J.; Balachandran, V. P.; Jarnagin, W. R.; Kingham, T. P.
    Journal of Surgical Oncology (2017)

    Fulltext@MSK | Save
  • Introduction to JSO global cancer edition
    Journal Article

    Kingham, T. P.; Are, C.
    Journal of Surgical Oncology (2017)

    Fulltext@MSK | Save
  • Priorities and funding for global cancer surgery research
    Journal Article

    Kingham, T. P.; Ginsburg, O.; Sivaram, S.; Ilbawi, A.; Trimble, T.
    Journal of Surgical Oncology (2017)

    Fulltext@MSK | Save
  • Evolving application of minimally invasive cancer operations at a tertiary cancer center
    Journal Article

    Selby, L. V.; DeMatteo, R. P.; Tholey, R. M.; Jarnagin, W. R.; Garcia-Aguilar, J.; Strombom, P. D.; Allen, P. J.; Kingham, T. P.; Weiser, M. R.; Brennan, M. F.; more...
    Journal of Surgical Oncology (2017)

    Fulltext@MSK | Save